Ubaka Ogbogu
Title
Cited by
Cited by
Year
Science communication reconsidered
T Bubela, MC Nisbet, R Borchelt, F Brunger, C Critchley, E Einsiedel, ...
Nature biotechnology 27 (6), 514-518, 2009
3622009
Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine
D Lau, U Ogbogu, B Taylor, T Stafinski, D Menon, T Caulfield
Cell stem cell 3 (6), 591-594, 2008
3292008
Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better?
U Ogbogu, C Rachul, T Caulfield
Regenerative medicine 8 (3), 361-369, 2013
792013
A review of the key issues associated with the commercialization of biobanks
T Caulfield, S Burningham, Y Joly, Z Master, M Shabani, P Borry, ...
Journal of Law and the Biosciences 1 (1), 94-110, 2014
672014
iPS cells: mapping the policy issues
A Zarzeczny, C Scott, I Hyun, J Bennett, J Chandler, S Chargé, H Heine, ...
Cell 139 (6), 1032-1037, 2009
642009
The stem cell research environment: a patchwork of patchworks
T Caulfield, A Zarzeczny, J McCormick, T Bubela, C Critchley, E Einsiedel, ...
Stem Cell Reviews and Reports 5 (2), 82-88, 2009
392009
Informed consent in embryonic stem cell research: Are we following basic principles?
T Caulfield, U Ogbogu, RM Isasi
Cmaj 176 (12), 1722-1725, 2007
372007
The commercialization of university-based research: Balancing risks and benefits
T Caulfield, U Ogbogu
BMC medical ethics 16 (1), 1-7, 2015
352015
Professional regulation: a potentially valuable tool in responding to “stem cell tourism”
A Zarzeczny, T Caulfield, U Ogbogu, P Bell, VA Crooks, K Kamenova, ...
Stem Cell Reports 3 (3), 379-384, 2014
302014
Research ethics and stem cells: Is it time to re‐think current approaches to oversight?
T Caulfield, K Kamenova, U Ogbogu, A Zarzeczny, J Baltz, S Benjaminy, ...
EMBO reports 16 (1), 2-6, 2015
262015
Patents, commercialization and the Canadian stem cell research community
T Caulfield, U Ogbogu, C Murdoch, E Einsiedel
Future Medicine Ltd 3 (4), 483-496, 2008
242008
Stem cell research ethics: consensus statement on emerging issues
T Caulfield, U Ogbogu, E Nelson, E Einsiedel, B Knoppers, M McDonald, ...
Journal of Obstetrics and Gynaecology Canada 29 (10), 843-848, 2007
232007
Health misinformation and the power of narrative messaging in the public sphere
T Caulfield, AR Marcon, B Murdoch, JM Brown, ST Perrault, J Jarry, ...
Canadian Journal of Bioethics/Revue canadienne de bioéthique 2 (2), 52-60, 2019
202019
Non-invasive prenatal testing and the unveiling of an impaired translation process
B Murdoch, V Ravitsky, U Ogbogu, S Ali-Khan, G Bertier, S Birko, ...
Journal of Obstetrics and Gynaecology Canada 39 (1), 10-17, 2017
202017
Chinese newspaper coverage of (unproven) stem cell therapies and their providers
U Ogbogu, L Du, C Rachul, L Bélanger, T Caulfield
Stem Cell Reviews and Reports 9 (2), 111-118, 2013
192013
Human gene editing: revisiting Canadian policy
BM Knoppers, R Isasi, T Caulfield, E Kleiderman, P Bedford, J Illes, ...
NPJ Regenerative medicine 2 (1), 1-2, 2017
182017
International stem cell environments: a world of difference
T Caulfield, A Zarzeczny, J McCormick, T Bubela, C Critchley, E Einsiedel, ...
Nature Reports Stem Cells 16, 1-5, 2009
162009
Biomedical research and the commercialization agenda: A review of main considerations for neuroscience
T Caulfield, U Ogbogu
Accountability in Research 15 (4), 303-320, 2008
142008
Community pharmacists’ views and practices regarding natural health products sold in community pharmacies
U Ogbogu, C Necyk
PloS one 11 (9), e0163450, 2016
132016
The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions
U Ogbogu, J Du, Y Koukio
BMC medical ethics 19 (1), 1-6, 2018
122018
The system can't perform the operation now. Try again later.
Articles 1–20